361197888	361197888	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
41332869	41332869	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
851008	851008	CD	B-NP	O
|	|	CC	I-NP	O
11/26/1995	11/26/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/11/1995	5/11/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/1995	11/19/1995	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
MYOCARDIAL	MYOCARDIAL	NNP	B-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	B-protein
POST	POST	NN	I-NP	I-protein
CHOLECYSTECTOMY	CHOLECYSTECTOMY	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

ASTHMA	ASTHMA	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
41	41	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
Afro-American	Afro-American	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
wall	wall	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
on	on	IN	B-PP	O
4/26/95	4/26/95	CD	B-NP	O
transferred	transfer	VBN	B-VP	O
from	from	IN	B-PP	O
Rahert	Rahert	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
postmyocardial	postmyocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

CARDIAC	CARDIAC	NN	B-NP	B-protein
RISK	RISK	NN	I-NP	I-protein
FACTORS	FACTORS	NN	I-NP	I-protein
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
postmenopausal	postmenopausal	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
previous	previous	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
and	and	CC	I-NP	O
a	a	DT	I-NP	O
half	half	NN	I-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
while	while	IN	B-SBAR	O
sorting	sort	VBG	B-VP	O
mail	mail	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
20	20	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
Cushing	Cushe	VBG	B-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
and	and	CC	I-NP	O
radiation	radiation	NN	I-NP	O
down	down	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
and	and	CC	O	O
across	across	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
thought	think	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
often	often	RB	B-ADVP	O
appeared	appear	VBD	B-VP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
eating	eat	VBG	B-VP	O
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
questionable	questionable	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
position	position	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
intervening	intervening	JJ	I-NP	O
period	period	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
additional	additional	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
HMC	HMC	NN	B-NP	B-cell_type
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Disalcid	Disalcid	NN	B-NP	O
and	and	CC	I-NP	O
Tagamet	Tagamet	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
persisted	persist	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
crescendo	crescendo	NN	I-NP	O
pattern	pattern	NN	I-NP	O
until	until	IN	B-PP	O
4/26/95	4/26/95	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
LSSHA	LSSHA	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
unrelenting	unrelente	VBG	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
Ai	Ai	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
CK	CK	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
1508	1508	CD	B-NP	O
MB	MB	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
.	.	.	O	O

MB	MB	NN	B-NP	B-protein
of	of	IN	B-PP	O
126	126	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
1900	1900	CD	B-NP	O
on	on	IN	B-PP	O
8/6	8/6	CD	B-NP	O
EKG	EKG	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
Q	Q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	O	O
ADF	ADF	NN	B-NP	B-protein
.	.	.	O	O

T	T	NN	B-NP	O
waves	wave	VBZ	B-VP	O
aversions	aversion	NNS	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
,	,	,	O	O
Metoprolol	Metoprolol	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
apparently	apparently	RB	B-ADVP	O
had	have	VBD	B-VP	O
additional	additional	JJ	B-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Campte	Campte	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	B-NP	O
hydrochlorothiazide	hydrochlorothiazide	NN	I-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
transfer	transfer	VB	B-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
included	include	VBD	B-VP	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Metoprolol	Metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Percocet	Percocet	NNP	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
seafood	seafood	NN	B-NP	O
-	-	HYPH	O	O
she	she	PRP	B-NP	O
gets	get	VBZ	B-VP	O
hives	hive	NNS	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
40	40	CD	I-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
her	her	PRP$	B-NP	O
father	father	NN	I-NP	O
and	and	CC	I-NP	O
mother	mother	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
smokes	smoke	VBZ	B-VP	O
one	one	CD	B-NP	O
pack	pack	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
cigarettes	cigarette	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Upon	Upon	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Mouth	Mouth	NNP	I-NP	O
-	-	HYPH	I-NP	O
Butlham	Butlham	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
130/85	130/85	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
pulse	pulse	NN	I-NP	O
is	be	VBZ	B-VP	O
79	79	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
exam	exam	NN	I-NP	O
-	-	HYPH	B-NP	O
sclerae	sclerae	NNS	I-NP	O
are	be	VBP	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
pupils	pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
-	-	HYPH	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poorly	poorly	RB	I-NP	O
healed	heal	VBN	I-NP	O
scar	scar	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
percussion	percussion	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
CVA	CVA	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
-	-	HYPH	B-NP	O
PMI	PMI	NN	I-NP	O
nondisplaced	nondisplaced	JJ	I-NP	O
,	,	,	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
split	split	JJ	B-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
whooshing	whooshing	JJ	I-NP	O
crescendo/decrescendo	crescendo/decrescendo	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
that	that	WDT	B-NP	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
-	-	HYPH	O	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
scar	scar	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Femoral	Femoral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
,	,	,	O	O
symmetrical	symmetrical	JJ	B-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

Reflexes	Reflex	NNS	B-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Toes	Toe	NNS	B-NP	O
were	be	VBD	B-VP	O
downgoing	downgoe	VBG	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
3.8	3.8	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
13.6	13.6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
37.8	37.8	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
of	of	IN	B-PP	O
179	179	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.3	2.3	CD	I-NP	O
and	and	CC	O	O
CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
201	201	CD	B-NP	O
,	,	,	O	O
PT-PTT	PT-PTT	NN	B-NP	B-protein
13.2	13.2	CD	I-NP	I-protein
,	,	,	I-NP	O
59	59	CD	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
or	or	CC	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
failure	failure	NN	B-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
SUMMARY	SUMMARY	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
41	41	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
who	who	WP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
experiencing	experience	VBG	I-VP	O
postmyocardial	postmyocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
pain	pain	NN	I-NP	O
either	either	CC	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
current	current	JJ	B-NP	O
angina	angina	NN	I-NP	O
versus	versus	IN	B-PP	O
pericarditis	pericarditis	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
evidence	evidence	NN	I-NP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
IH	IH	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blocker	blocker	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
after	after	IN	B-PP	O
transfer	transfer	NN	B-NP	O
with	with	IN	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Prednisone	Prednisone	NN	B-NP	O
x	x	SYM	B-NP	O
two	two	CD	B-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
shellfish	shellfish	NN	B-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
10/12/95	10/12/95	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
being	be	VBG	B-VP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
filling	filling	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
weight	weight	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
OM	OM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
first	first	RB	B-NP	O
large	large	JJ	I-NP	O
OM	OM	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
nonobstructive	nonobstructive	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
distal	distal	JJ	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein

The	The	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
were	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
7	7	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Coronary	Coronary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stepdown	stepdown	JJ	I-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
postcatheterization	postcatheterization	NN	B-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bruit	bruit	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
there	there	EX	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
done	done	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
7	7	CD	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
20.7	20.7	CD	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	O
of	of	IN	B-PP	O
74.3	74.3	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
2-3-S	2-3-S	NN	B-NP	O
,	,	,	O	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
EKG	EKG	NNP	B-NP	O
's	's	POS	B-NP	O
from	from	IN	B-PP	O
1/7	1/7	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
MI	MI	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lesion	lesion	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Prednisone	Prednisone	NN	I-NP	O
given	give	VBN	B-VP	O
as	as	IN	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
does	doe	NNS	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
75	75	CD	B-NP	O
mg	mg	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60	60	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stepdown	stepdown	JJ	I-NP	O
unit	unit	NN	I-NP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
monitor	monitor	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
29	29	CD	I-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
pain	pain	NN	I-NP	O
3	3	CD	I-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
,	,	,	O	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
associated	associate	VBN	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
slight	slight	JJ	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
weaned	wean	VBN	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
were	be	VBD	B-VP	O
130/90	130/90	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
murmurs	murmur	NNS	I-NP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

Lung	Lung	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	B-protein
wave	wave	NN	I-NP	I-protein
inversion	inversion	NN	I-NP	I-protein
and	and	CC	O	I-protein
3	3	CD	B-NP	I-protein
and	and	CC	O	O
R	R	NN	B-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
old	old	JJ	B-ADJP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
ST	ST	JJ	B-NP	O
segment	segment	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
old	old	JJ	B-ADJP	O
and	and	CC	O	O
suitable	suitable	JJ	B-NP	O
normalization	normalization	NN	I-NP	O
in	in	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
dialed	dial	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
likewise	likewise	RB	I-VP	O
given	give	VBN	I-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
push	push	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
for	for	IN	B-PP	O
recontrol	recontrol	NN	B-NP	O
and	and	CC	O	O
Serax	Serax	NN	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
x	x	SYM	O	O
one	one	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
interventions	intervention	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
arm	arm	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
described	describe	VBD	B-VP	O
it	it	PRP	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
heaviness	heaviness	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
144/87	144/87	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
was	be	VBD	B-VP	O
74	74	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
75	75	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
3R	3R	NN	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
,	,	,	O	O
V3	V3	NN	B-NP	B-protein
,	,	,	O	O
V5	V5	NN	B-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
sinusoidality	sinusoidality	NN	I-NP	O
and	and	CC	O	O
V6	V6	NN	B-NP	B-protein
T	T	NN	I-NP	I-protein
wave	wave	VBP	B-VP	O
slightly	slightly	RB	I-VP	O
inverted	invert	VBN	I-VP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
dialed	dial	VBN	I-VP	O
up	up	RP	B-PRT	O
further	further	RBR	B-ADVP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
was	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
pain-free	pain-free	JJ	B-ADJP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
interventions	intervention	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
late	late	JJ	I-NP	O
recontrol	recontrol	NN	I-NP	O
.	.	.	O	O

Duration	Duration	NN	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
episode	episode	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain-free	pain-free	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
wit	wit	NN	I-NP	O
V5	V5	NN	I-NP	O
T	T	NN	I-NP	O
wave	wave	VBP	B-VP	O
more	more	RBR	B-ADJP	O
upright	upright	JJ	I-ADJP	O
than	than	IN	B-PP	O
sinusoidal	sinusoidal	JJ	B-NP	O
and	and	CC	I-NP	O
V6	V6	NN	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
upright	upright	RB	B-ADVP	O
,	,	,	O	O
else	else	RB	B-NP	O
no	no	DT	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
IV	IV	CD	I-NP	O
TNG	TNG	NN	I-NP	O
was	be	VBD	B-VP	O
dialed	dial	VBN	I-VP	O
up	up	RP	B-PRT	O
further	further	RBR	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
129/76	129/76	CD	B-NP	O
and	and	CC	O	O
rate	rate	NN	B-NP	O
was	be	VBD	B-VP	O
now	now	RB	B-ADVP	O
70	70	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
bolus	bolus	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
morphine	morphine	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
and	and	CC	I-NP	O
Isoenzymes	Isoenzyme	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
Cardiology	Cardiology	NNP	B-NP	O
attending	attend	VBG	B-VP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
aware	aware	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
NPO	NPO	NN	B-NP	B-protein
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
if	if	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
recur	recur	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
CK	CK	NN	I-NP	O
following	follow	VBG	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
was	be	VBD	B-VP	O
magnified	magnify	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
triponin	triponin	NN	I-NP	O
I	I	CD	I-NP	O
of	of	IN	B-PP	O
14.1	14.1	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
29	29	CD	I-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
appropriate	appropriate	JJ	B-ADJP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
heparin	heparin	NN	I-NP	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
control	control	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
deemed	deem	VBN	I-VP	O
appropriate	appropriate	JJ	B-ADJP	O
to	to	TO	B-PP	O
considering	consider	VBG	B-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
20	20	CD	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
PTCA	PTCA	NN	I-NP	O
performed	perform	VBN	B-VP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
distal	distal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
which	which	WDT	B-NP	O
left	leave	VBD	B-VP	O
a	a	DT	B-NP	O
residual	residual	JJ	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
0	0	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
stents	stent	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
0	0	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-NP	O
postcatheterization	postcatheterization	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
remarkable	remarkable	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
postcatheterization	postcatheterization	NN	I-NP	O
was	be	VBD	B-VP	O
64	64	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
18	18	CD	I-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Atenolol	Atenolol	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
on	on	IN	B-PP	O
6	6	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
68	68	CD	I-NP	O
to	to	TO	I-NP	O
75	75	CD	I-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
120/75	120/75	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
were	be	VBD	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
coumadinized	coumadinize	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
18	18	CD	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
supertherapeutic	supertherapeutic	JJ	I-NP	O
response	response	NN	I-NP	O
coumadinization	coumadinization	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
5.7	5.7	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
recheck	recheck	VB	I-VP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
to	to	TO	B-VP	O
secure	secure	VB	I-VP	O
a	a	DT	B-NP	O
downward	downward	JJ	I-NP	O
trend	trend	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
planning	plan	VBG	I-VP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
24	24	CD	I-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
4.6	4.6	CD	B-NP	O
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
a	a	DT	B-NP	O
downward	downward	JJ	I-NP	O
trend	trend	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
maximum	maximum	JJ	I-NP	O
INR	INR	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
supertherapeutic	supertherapeutic	JJ	B-ADJP	O
,	,	,	O	O
of	of	IN	B-PP	O
6.5	6.5	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mathur	Mathur	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Stailey	Stailey	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
For	For	NNP	I-NP	O
Nali	Nali	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Anusol	Anusol	NNP	B-NP	O
Suppositories	Suppositories	NNP	I-NP	O
one	one	CD	B-NP	O
suppository	suppository	JJ	I-NP	O
pr	pr	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q	q	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x	x	SYM	B-NP	O
three	three	CD	B-NP	O
prn	prn	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
b.i.d.	b.i.d.	IN	B-PP	O
Diet	Diet	NNP	B-NP	O
-	-	HYPH	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
saturated	saturated	JJ	I-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LANE	LANE	NNP	B-NP	O
STRYJEWSKI	STRYJEWSKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CC04	CC04	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WINFRED	WINFRED	NNP	B-NP	O
G.	G.	NNP	I-NP	O
DACANAY	DACANAY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DC25	DC25	NNP	I-NP	O
KJ198/1872	KJ198/1872	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
60202	60202	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

H7YANJ7YYY	H7YANJ7YYY	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/30/96	9/30/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/30/96	9/30/96	CD	B-NP	O

